SRRM2
protein-codingserine/arginine repetitive matrix 2, the group of Spliceosomal C complex|Spliceosomal P complex|NTC associated proteins
Gene summary
Enables C2H2 zinc finger domain binding activity. Involved in mRNA splicing, via spliceosome. Located in Cajal body and nuclear speck. Part of U2-type catalytic step 2 spliceosome and U2-type precatalytic spliceosome. Implicated in autosomal dominant intellectual developmental disorder 72. Biomarker of Parkinson's disease. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~19.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0957397
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0957397
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0957397
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0957397
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SRRM2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_016333.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 95 | 6 | 108 | ||
| missense | 1 | 864 | 160 | 11 | 1036 | |
| nonsense | 23 | 14 | 37 | |||
| start loss | 0 | |||||
| frameshift | 25 | 14 | 6 | 45 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 8 | 1 | 11 | |
| Total | 49 | 30 | 885 | 256 | 17 | 1237 |
Highest pathogenic variant AF is 0.0000065727204
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_057417.3 | 14 | MANE Select | |
| Ensembl | ENSP00000301740.8 | 14 | MANE Select | |
| Ensembl | ENSP00000484503.1 | 8 | Standard | |
| Ensembl | ENSP00000458647.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Metabolism of RNA
- mRNA Splicing - Major Pathway
- mRNA Splicing
- Processing of Capped Intron-Containing Pre-mRNA
Biological Process
- mRNA splicing, via spliceosome
Molecular Function
- RNA binding
- protein N-terminus binding
- C2H2 zinc finger domain binding
Cellular Component
- nucleus
- nucleoplasm
- Cajal body
- nuclear speck
- U2-type catalytic step 2 spliceosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000301740
- Coding exons
- 14
- Length
- 20210
- Individuals with no LoFs
- 125726
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 22
- Defined
- 125748
- p
- 0.0000875
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -6.28 | 2410 | 1.68e+3 | 1.43 | 0.000120 | 17102 |
| Missense (PolyPhen) | 276 | 238.17 | 1.1588 | 2512 | ||
| Synonymous | -13.2 | 1030 | 615 | 1.67 | 0.0000360 | 6516 |
| Loss of Function | 9.16 | 7 | 111 | 0.0628 | 0.00000949 | 1060 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00012 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00011 | 0.00011 | rare |
| South Asian | 0.000065 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in pre-mRNA splicing. May function at or prior to the first catalytic step of splicing at the catalytic center of the spliceosome. May do so by stabilizing the catalytic center or the position of the RNA substrate (By similarity). Binds to RNA. {ECO:0000250, ECO:0000269|PubMed:10668804}.;
Recessive Scores
- pRec
- 0.235
Intolerance Scores
- LoFtool
- 0.174
- RVIS EVS
- -4.51
- RVIS percentile EVS
- 0.08
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.699
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |